Advertisement

Diagnostische Kriterien

  • H. Michels
  • R. Häfner
  • L. Köhler
  • H. Zeidler
  • P. Herzer
  • G. R. Burmester
  • E. Genth
  • E. Gromnica-Ihle
  • C. Specker
  • M. Schneider
  • P. Vaith
  • H. H. Peter
  • W. L. Gross
  • B. Manger
  • W. Keitel
  • G. Weseloh
  • B. Swoboda
  • H. H. Raspe
  • H. Häntzschel
  • J. D. Ringe
  • R. Dreher
Part of the Qualitätssicherung in der Rheumatologie book series (QUALRHEUM, volume 1)

Auszug

Bei rheumatischen Erkrankungen ist nur selten die Ursache bekannt. Dort, wo dies der Fall ist, erfolgt die Klassifikation und Beschreibung der Erkrankung ursachenbezogen (z. B. infektiöse Arthritis).

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Fries JF, Hochberg MC, Medsger Jr TA, Hunder GG, Bombardier C and the American College of Rheumatology Diagnostic and Therapeutic Criteria Committee (1994) Criteria for rheumatic disease: different types and different functions. Arthritis Rheum 37:454–462PubMedCrossRefGoogle Scholar
  2. 2.
    Mathies H (Hrsg) (1984) Leitfaden für Diagnose und Therapie rheumatischer Erkrankungen. EULAR, BaselGoogle Scholar

Literatur

  1. 1.
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, Medsger TA Jr, Mitchell DM, Neustadt DH, Pinals RS, Schaller JG, Sharp JT, Wilder RL, Hunder GG (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthr Rheum 31:315–324CrossRefGoogle Scholar
  2. 2.
    Ropes MW, Bennett EA, Cobb S, Jacox R, Jessar R (1958) Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9:175–176PubMedGoogle Scholar
  3. 3.
    Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Brewer EJ, Bass J, Baum J, Cassidy JT, Fink CW, Jacobs JC, Hanson V, Levinson JF, Schaller JG, Stillman JS (1977) Current proposed revision of JRA criteria. Arthr Rheum 20(suppl):195–199Google Scholar
  2. 2.
    Häfner R (2002) Juvenile idiopathische Arthritis. Die neue Nomenklatur und Klassifikation der chronischen Arthritis im Kindesalter. Akt Rheumatol 27:18–21CrossRefGoogle Scholar
  3. 3.
    Lambert JR, Ansell BM, Stephenson E, Wright V (1976) Psoriatic arthritis in childhood. Clin Rheum Dis 2:339–352Google Scholar
  4. 4.
    Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997. J Rheumatol 25:1991–1994PubMedGoogle Scholar
  5. 5.
    Southwood TR, Petty RE, Malleson PN, Delgado EA, Hunt DW, Wood B, Schroeder ML (1989) Psoriatic arthritis in children. Arthr Rheum 32:1007–1013CrossRefGoogle Scholar
  6. 6.
    Wood PHN (1978) Special meeting on nomenclature and classification of arthritis in children. In: Munthe E (ed) The care of rheumatic children. EULAR publishers, pp 47–50Google Scholar

Literatur

  1. 1.
    Calin A, Parta J, Fries JF, Schurmann DJ (1977) Clinical history as a screening test for ankylosing spondylitis. J Am Med Assn 237:2613–2614CrossRefGoogle Scholar
  2. 2.
    Dougados M, Van der Linden S, Julien R, Huitfeldt B, Amor B, Calin A, Cats A, Dijkmans I, Olivieri I, Pasero G, Veys E, Zeidler H and the European Spondylarthropathy Study Group (1991) The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthr Rheum 34:1218–1230CrossRefGoogle Scholar
  3. 3.
    Mau W, Zeidler H (2001) Sonstige entzündliche Spondylarthropathien. In: Zeidler, Zacher, Hiepe (Hrsg) Interdisziplinäre klinische Rheumatologie. Springer, Berlin, Heidelberg, New York, S 1019–1025Google Scholar
  4. 4.
    Moll JM, Haseler J, Macral IF, Wright V (1974) Association between ankylosing spondylitis, psoriatic arthritis, Reiter’s disease, the intestinal arthropathies and Behçet-syndrome. Medicine 53:343–357PubMedCrossRefGoogle Scholar
  5. 5.
    Silman A (2001) Ankylosing spondylitis and spondylarthropathies. In: Silman A, Hochberg MC (eds) Epidemiology of rheumatic diseases. University Press, Oxford, pp 100–111Google Scholar
  6. 6.
    Zeidler H, Mau W, Kahn MA (1992) Undifferentiated spondylarthropathies. Rheum Dis Clin North Am 18:187–198PubMedGoogle Scholar

Literatur

  1. 1.
    Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Stangel W, Deicher H (1990) Evaluation of early diagnostic criteria for ankylosing spondylitis in a 10 year follow-up. Z Rheumatol 49:82–87PubMedGoogle Scholar
  2. 2.
    Mau W, Zeidler H (2001) Spondylitis ankylosans. In: Zeidler H, Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie. Springer, Berlin, Heidelberg, New York, S 1004–1019Google Scholar

Literatur

  1. 1.
    Mathies H (1984) Arthritis psoriatica. In: Mathies H, Schneider P (Hrsg) Rheumatische Krankheiten. Kompendium für die Praxis Deutscher Ärzte-Verlag, KölnGoogle Scholar
  2. 2.
    Genth E (2001) Arthritis psoriatica. In: Zeidler H, Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie. Springer, Berlin, Heidelberg, New York, S 662–669Google Scholar

Literatur

  1. 1.
    Aho K, Leirisalo-Repo M, Repo H (1985) Reactive arthritis. Clin Rheumat Dis 11:25–40Google Scholar
  2. 2.
    Fan PT, Yü DTH (1993) Reiter’s syndrome. In: Schumacher RD (ed) Primer on the rheumatic diseases. Arthritis Foundation, Atlanta Georgia, pp 158–161Google Scholar
  3. 3.
    Inman RD (1993) Reactive arthritis after infectious enteritis. In: Schumacher RD (ed) Primer on the rheumatic diseases. Arthritis Foundation, Atlanta, Georgia, pp 166–168Google Scholar
  4. 4.
    Sieper J, Rudwaleit M, Braun J, van der Heijde D (2002) Diagnosing reactive arthritis: role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 46:319–327PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Stollerman GH, Markowitz M, Taranta A, Wannamake LW, Whittemore R (1965) Jones Criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation: pp 664–668Google Scholar
  2. 2.
    Stollerman GH (1997) Rheumatic fever. Lancet 349(9056):935–942PubMedCrossRefGoogle Scholar
  3. 3.
    Carapetis JR, McDonald M, Wilson NJ (2005) Acute rheumatic fever. Lancet 366:155–168PubMedCrossRefGoogle Scholar

Literatur

  1. Herzer P (1991) Joint manifestations of Lyme borreliosis in Europe. Scand J Infect Dis (suppl) 77:55–63Google Scholar
  2. Krause A, Burmester G (1999) Lyme-Borreliose. Thieme, Stuttgart, New YorkGoogle Scholar
  3. Krause A, Herzer P (2005) Frühdiagnose der Lyme-Arthritis. Z Rheumatol 64:531–537PubMedCrossRefGoogle Scholar
  4. Steere AC (1987) The clinical evolution of Lyme arthritis. Ann Intern Med 107:725–731PubMedGoogle Scholar
  5. Steere AC (2001) Lyme disease. N Engl J Med 345:115–125PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Daniels TE, Whitcher JP (1994) Association of patterns of labial salivary gland inflammation with keratoconjunctivitis sicca. Analysis of 618 patients with suspected Sjögren’s syndrome. Arthritis Rheum 37:869–877PubMedCrossRefGoogle Scholar
  2. 2.
    Fox RI, Robinson CA, Curd JG, Kozin F, Howell FV (1986) Sjögrens syndrome: proposed criteria for classification. Arthritis Rheum 29:577–585PubMedCrossRefGoogle Scholar
  3. 3.
    Homma M, Tojo T, Akizuki M, Yagomata H (1986) Criteria für Sjögren’s syndrome in Japan. Scand J Rheumatol (Suppl) 61:26–27Google Scholar
  4. 4.
    Manthorpe R, Oxholm P, Prause JU, Schiödt M (1986) The Copenhagen criteria for Sjögren’s syndrome. Scand J Rheumatol (Suppl) 61:19–21Google Scholar
  5. 5.
    Rubin H, Holt M (1957) Secretory sialography in diseases of the major salivary glands. Am J Roentgenol 77:575–598Google Scholar
  6. 6.
    Shall GL, Anderson LG, Wolf RO et al (1971) Xerostomia in Sjögren’s syndrome: evaluation by sequential scintigraphy. JAMA 216:2109–2116CrossRefGoogle Scholar
  7. 7.
    Skopouli FN, Drosos AA, Papioannou T, Moutsopoulos HM (1986) Preliminary diagnostic criteria for Sjögren’s syndrome. Scand J Rheumatol (Suppl) 61:22–25Google Scholar
  8. 8.
    Vitali C, Bombardieri S, Moutsopoulos HM et al (1993) Preliminary criteria for the classification of Sjögren’s syndrome. Arthritis Rheum 36:340–347PubMedCrossRefGoogle Scholar
  9. 9.
    Viali C, Bombardieri S, Moutsopoulos HM et al (1996) Assessment of the European classification criteria for Sjögren’s syndrome in a series of slinically defined cases. Results of a prospective multicentre study. Ann Rheum Dis 55:116–121Google Scholar
  10. 10.
    Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM et al (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61:554–558PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277PubMedCrossRefGoogle Scholar
  2. 2.
    Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725PubMedCrossRefGoogle Scholar
  3. 3.
    Gaubitz M, Schotte H (2005) Frühdiagnose des systemischen Lupus erythematodes (SLE). Z Rheumatol 64:547–552PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Arnout J, Meijer P, Vermylen J (1999) Lupus anticoagulant testing in Europe: an analysis of results from the first European Concerted Action on Thrombophilia (ECAT) survey using plasmas spiked with monoclonal antibodies against human beta2-glycoprotein I. Thromb Haemost 81:929–934PubMedGoogle Scholar
  2. 2.
    Asherson RA, Cervera R, Piette JC et al (2001) Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine 80:355–377PubMedCrossRefGoogle Scholar
  3. 3.
    Brandt JT, Barna LK, Triplett DA (1995) Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants/Antiphospholipid Antibodies of the ISTH. Thromb Haemost 74:1597–1603PubMedGoogle Scholar
  4. 4.
    Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum 46:1019–1027PubMedCrossRefGoogle Scholar
  5. 5.
    Conley CL, Hartmann RC (1952) A haemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematodes. J Clin Invest 31:621–622Google Scholar
  6. 6.
    Gromnica-Ihle E, Schößler W (2000) Antiphospholipid syndrome. Int Arch Allergy Immunol 123:67–76PubMedCrossRefGoogle Scholar
  7. 7.
    Hughes GRV (1983) Thrombosis, abortion, cerebral disease and lupus anticoagulant. Br Med J 187:1088–1089Google Scholar
  8. 8.
    Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306PubMedCrossRefGoogle Scholar
  9. 9.
    Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Masi AT, Rodnan GP, Medsger TA, Altman RD, D’Angelo WA, Fries JF, LeRoy EC, Kirsner AB, MacKenzie AH, McShane DJ, Myers AR, Sharf GC (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–590CrossRefGoogle Scholar

Literatur

  1. 1.
    Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347PubMedCrossRefGoogle Scholar
  2. 2.
    Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407PubMedCrossRefGoogle Scholar
  3. 3.
    Genth E, Mierau R (1995) Diagnostische Bedeutung Sklerodermie-und Myositisassoziierter Autoantikörper. Z Rheumatol 54:39–49PubMedGoogle Scholar
  4. 4.
    Targoff IN (1992) Autoantibodies in polymyositis. Rheum Dis Clin North Am 18:455–482PubMedGoogle Scholar
  5. 5.
    Vogel H (1998) Inclusion body myositis — a review. Adv Anat Pathol 5:164–169PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PNH (1979) An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 38:434–439PubMedGoogle Scholar
  2. 2.
    Blockmans D, Stroobants S, Maes A, Mortelmans L (2000) Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 108:246–249PubMedCrossRefGoogle Scholar
  3. 3.
    Cantini F, Salvarani C, Olivieri I, Barozzi L, Macchioni L, Niccoli L, Padula A, Pavlica P, Boiardi L (1999) Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study. Ann Rheum Dis 58:230–236PubMedGoogle Scholar
  4. 4.
    Cantini F, Salvarani C, Olivieri I, Niccoli L, Padula A, Macchioni L, Boiardi L, Ciancio G, Mastrorosato M, Rubini F, Bozza A, Zanfranceschi G (2001) Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. J Rheumatol 28:1049–1055PubMedGoogle Scholar
  5. 5.
    Evans JM, Hunder GG (2000) Polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin North America 26:493–515CrossRefGoogle Scholar
  6. 6.
    Gerber N (1978) Polymyalgia rheumatica. Ein Teilaspekt der Riesenzellarteriitis. Erg Inn Med Kinderheilk 40:85–149Google Scholar
  7. 7.
    Kaiser H (1987) Polymyalgia rheumatica — eine immer noch zu wenig bekannte Krankheit. Internist Welt 1:13–23Google Scholar
  8. 8.
    Vaith P, Hänsch GM, Peter HH (1988) C-reactive protein-mediated complement activation in polymyalgia rheumatica and other systemic inflammatory diseases. Rheumatol Int 8:71–80PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Evans JM, Hunder GG (2000) Polymyalgia rheumatica and giant cell arteritis. Rheum Dis Clin North America 26:493–515CrossRefGoogle Scholar
  2. 2.
    Gerber N (1989) Polymyalgia rheumatica und andere Varianten der Riesenzellarteriitis. In: Fehr K, Miehle W, Schattenkirchner M, Tillmann K (Hrsg) Rheumatologie in Praxis und Klinik. Thieme, Stuttgart New York, pp 11.81–11.96Google Scholar
  3. 3.
    Hazleman B, Bengtsson AA (eds) (1991) Giant cell arteritis. Bailliere’s Clin Rheumatol, Tindall, LondonGoogle Scholar
  4. 4.
    Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthr Rheum 33:1122–1128CrossRefGoogle Scholar
  5. 5.
    Liozon E, Herrmann F, Ly K, Robert PY, Loustaud V, Soria P, Vidal E (2001) Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med 111:211–217PubMedCrossRefGoogle Scholar
  6. 6.
    Rao JK, Allen NB, Pincus T (1998) Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Int Med 129:345–352PubMedGoogle Scholar
  7. 7.
    Schmidt D (1995) Arteriitis temporalis Horton. Diagnose, Differentialdiagnose, Therapie. Elephas, St. GallenGoogle Scholar
  8. 8.
    Schmidt D, Vaith P, Hetzel A (2000) Prevention of ophthalmic and cerebral complications in temporal arteritis? Clin Exp Rheumatol 18(suppl 20):S61–S63PubMedGoogle Scholar
  9. 9.
    Schmidt WA, Kraft HE, Vorpahl K, Volker L, Gromnica-Ihle EJ (1997) Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 337: 1336–1342PubMedCrossRefGoogle Scholar

Literatur

  1. 1.
    Arend WP, Michel BA, Bloch DA, Hunder GG, Calabrese LH, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthr Rheum 33:1129–1134CrossRefGoogle Scholar
  2. 2.
    Atalay MK, Bluemke DA (2001) Magnetic resonance imaging of large vessel vasculitis. Curr Opin Rheumatol 13:41–47PubMedCrossRefGoogle Scholar
  3. 3.
    Ishikawa K (1988) Diagnostic approach and proposed criteria for the diagnosis of Takayasu’s arteriopathy. J Am Coll Cardiol 12:964–972PubMedCrossRefGoogle Scholar
  4. 4.
    Hall S, Buchbinder R (1990) Takayasu’s arteritis. Rheum Dis Clin North Am 16: 411–422PubMedGoogle Scholar
  5. 5.
    Krause T, Schühlen H, Vaith P, Moser E (1993) Positive ventilation-perfusion lung scan and positive Tl-201 myocardial scintigraphy due to Takayasu’s arteritis. Clin Nucl Med 18:130–134PubMedCrossRefGoogle Scholar
  6. 6.
    Kerr G (1994) Takayasu’s arteritis. Curr Opin Rheumatol 6:32–38PubMedCrossRefGoogle Scholar
  7. 7.
    Kerr G (1995) Takayasu’s arteritis. Rheum Dis Clin North Am 21:1041–1053PubMedGoogle Scholar

Literatur

  1. 1.
    Gross WL (ed) (1993) ANCA associated vasculitides, Vol 336. Adv Exp Med Biol, Plenum Press, New York LondonGoogle Scholar
  2. 2.
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthr Rheum 37:187–192CrossRefGoogle Scholar
  3. 3.
    Kussmaul A, Maier K (1866) Über eine bisher nicht beschriebene eigenthümliche Arterienerkrankung (Periarteritis nodosa), die mit Morbus Brightii und rapid fortschreitender allgemeiner Muskellähmung einhergeht. Dtsch Arch Klin Med I: 484–515Google Scholar
  4. 4.
    Lightfoot RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT, Masi AT, Mills JA, Stevens MB, Wallace SL (1990) The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthr Rheum 33:1088–1093CrossRefGoogle Scholar
  5. 5.
    Ruiter M (1958) The so-called cutaneous type of periarteritis nodosa. Brit J Dermatol 70:102–120CrossRefGoogle Scholar
  6. 6.
    Wohlwill F (1923) Über eine nur mikroskopisch erkennbare Form der Periarteriitis nodosa. Virch Arch Pathol 246:377–411CrossRefGoogle Scholar

Literatur

  1. 1.
    Dillon MJ (1993) Primary vasculitis in children. In: Maddison PJ (ed) Oxford Textbook of Rheumatology. Oxford University Press, pp 889–894Google Scholar
  2. 2.
    Hicks RV, Melish ME (1986) Kawasaki syndrome. Pediat Clin North America 33:1151–1175Google Scholar
  3. 3.
    Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement and with specific desquamation of the fingers and toes in children. Japanese J Allergy 16:178–222Google Scholar
  4. 4.
    Levin M, Dillon MJ (1991) Kawasaki disease. In: Champion RH, Pye RJ (eds) Recent advances in dermatology. Churchill Livingstone, Edinburgh, pp 81–93Google Scholar
  5. 5.
    Rieger C (1987) Vaskulitiden und seltene Autoimmunerkrankungen. In: Pädiatrische Allergologie und Immunologie. Fischer, Stuttgart New York, S 507–522Google Scholar

Literatur

  1. 1.
    Gross WL (1999) Primär systemische Vaskulitiden Teil I/II. Der Internist 40:779–794, 951–968PubMedCrossRefGoogle Scholar
  2. 2.
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthr Rheum 37:187–192CrossRefGoogle Scholar
  3. 3.
    Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, Calabrese LH, Fries JF, Lie JT, Lightfoot RW, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of Wegener’s Granulomatosis. Arthr Rheum 33:1101–1107CrossRefGoogle Scholar
  4. 4.
    Moins-Teisserenc HT, Gadola SD, Cella M, Dunbar PR, Exley A, Blake N, Baykal C, Lambert J, Bigliardi P, Willemsen M, Jones M, Buechner S, Colonna M, Gross WL, Cerundolo V, Baycal C (1999) Association of a syndrome resembling Wegener’s granulomatosis with low surface expression of HLA class-I molecules. Lancet 6, 354(9190):1598–1603CrossRefGoogle Scholar

Literatur

  1. 1.
    Chumbley LC, Harrison EG Jr, DeRemee RA (1977) Allergic granulomatosis and angiitis (Churg-Strauss syndrome): Report and analysis of 30 cases. Mayo Clin Proc 52:477–484PubMedGoogle Scholar
  2. 2.
    Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27:277–301PubMedGoogle Scholar
  3. 3.
    Jennette JC, Palk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen C, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico A, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthr Rheum 37:187–192CrossRefGoogle Scholar
  4. 4.
    Masi A, Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, Calabrese LA, Edworthy SM, Fauci AS, Leavitt RY, Lightfoot RW Jr, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthr Rheum 33:1094–1100CrossRefGoogle Scholar

Literatur

  1. 1.
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen C, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico A, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthr Rheum 37:187–192CrossRefGoogle Scholar
  2. 2.
    Savage COS, Winearls CG, Evans DJ, Rees AJ, Lockwood CM (1985) Microscopic polyarteritis: presentation, pathology and prognosis. Quart J Med 220:467–483Google Scholar
  3. 3.
    Guillevin L, Durand-Gasselin B, Cevallos R, Gayraud M, Lhote F, Callard P, Amouroux J, Casassus P, Jarrousse B (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthr Rheum 42:421–430CrossRefGoogle Scholar
  4. 4.
    Jennette JC, Thomas DB, Falk RJ (2001) Microscopic polyangiitis (microscopic polyarteritis). Semin Diagn Pathol 18:3–13PubMedGoogle Scholar

Literatur

  1. 1.
    Henoch EH (1874) Über eine eigenthümliche Form von Purpura. Berliner Klin Wschr 11:641–643Google Scholar
  2. 2.
    Dillon MJ (1993) Primary vasculitis in children. In: Maddison PJ (ed) Oxford Textbook of Rheumatology. Oxford University Press, pp 889–894Google Scholar
  3. 3.
    Gross WL (1996) Primäre Vaskulitiden. In: Peter HH, Pichler W (Hrsg) Klinik der Gegenwart. Urban & Schwarzenberg, MünchenGoogle Scholar
  4. 4.
    Mills JA, Michel BA, Bloch DA, Calabrese LH, Hunder GG, Arend WP, Edworthy SM, Fauci AS, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, McShane DJ, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthr Rheum 33:1114–1121CrossRefGoogle Scholar

Literatur

  1. 1.
    Abel G, Zhang QX, Agnello V (1993) Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthr Rheum 36:1341–1349CrossRefGoogle Scholar
  2. 2.
    Bartels M, Ellendorf C, Peter HH, Schedel I (1980) Hämorrhagische Diathese bei Kryofibrinogenämie. In: Schimpf K (Hrsg) Fibrinogen, Fibrin und Fibrinkleber. Schattauer, Stuttgart, S 175–183Google Scholar
  3. 3.
    Brouet JC (1974) Biological and clinical significance of cryoglobulins. Am J Med 57:775–788PubMedCrossRefGoogle Scholar
  4. 4.
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthr Rheum 37:187–192CrossRefGoogle Scholar
  5. 5.
    Meltzer M, Franklin EC (1966) Cryoglobulinemia — a study of 29 patients. Am J Med 40:628–635CrossRefGoogle Scholar
  6. 6.
    Moroz LA, Rose B (1978) The cryopathies. In: Samter M (ed) Immunological Diseases, Vol I, 3rd ed. Little Brown, Boston, pp 570–591Google Scholar

Literatur

  1. 1.
    Braverman IM (ed) (1970) Skin Signs of Systemic Diseases. Saunders, Philadelphia, pp 199–238Google Scholar
  2. 2.
    Calabrese LH, Michel BA, Bloch DA, Arend WP, Edworthy SM, Fauci AS, Fries JF, Hunder GG, Leavitt RY, Lie JT, Lightfoot RW Jr, Masi AT, McShane DJ, Mills JA, Stevens MB, Wallace SL, Zvaifler NJ (1990) The American College of Rheumatology 1990 criteria for the classification of hypersensitivity vasculities. Arthr Rheum 33:1108–1113CrossRefGoogle Scholar
  3. 3.
    Grattan CH (1993) Small vessel vasculitis. In: Maddison PJ, Oxford Textbook of Rheumatology. Oxford University Press, pp 860–863Google Scholar
  4. 4.
    Gross WL (1994) Nicht ANCA-assoziierte Vaskulitiden. Klinik der Gegenwart. Urban & Schwarzenberg, MünchenGoogle Scholar
  5. 5.
    Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A (1994) Nomenclature of systemic vasculitides. Proposal of an International Consensus Conference. Arthr Rheum 37:187–192CrossRefGoogle Scholar
  6. 6.
    Peter HH (1991) Vaskulitiden. In: Peter HH (Hrsg) Klinische Immunologie. Urban & Schwarzenberg, München, S 401–414Google Scholar

Literatur

  1. 1.
    Dilsen N, Konica M, Aral O, Öcal L, Inanc M, Gül A (1993) Comparative study of the skin pathergy test with blunt and sharp needles in Behcçet’s disease: confirmed specifity but decreased sensitivity with sharp needles. An Rheum Dis 52:823–825CrossRefGoogle Scholar
  2. 2.
    International Study Group for Behcçet’s Disease (1990) Criteria for diagnosis of Behcçet’s disease. Lancet 335:1078–1080Google Scholar
  3. 3.
    Lawton G, Chamberlain MA, Bhakta B, Tennant A (2002) The Behcçet’s disease activity index (BDAI). 10th Internat Conf on Behcçet’s Disease, Berlin, Abstr No 009Google Scholar
  4. 4.
    Lee S, Bang D, Lee E-S, Sohn S (2001) Behcçet’s Disease. Textbook and Atlas. Springer, Berlin Heidelberg New YorkGoogle Scholar
  5. 5.
    Shimizu T, Ehrlich GE, Inawa G, Hayashi K (1979) Behcçet disease (Behcçet syndrome). Semin Arthr Rheum 8:223–260CrossRefGoogle Scholar
  6. 6.
    Zouboulis ChC (1996) Morbus Adamantiades-Behcçt in Deutschland: Historischer Rückblick und aktueller Kenntnisstand. Z Hautkr 71:491–501Google Scholar

Literatur

  1. 1.
    Mertz DP (1993) Gicht, 6. Aufl. Thieme, Stuttgart New YorkGoogle Scholar
  2. 2.
    Pascual E (2000) Gout update: from lab to the clinic and back. Current Opin Rheumatol 12:211–212CrossRefGoogle Scholar
  3. 3.
    Schattenkirchner M, Gröbner W (2000) Arthropathia urica. In: Miehle W, Fehr K, Schattenkirchner M, Tillmann K (Hrsg) Rheumatologie in Praxis und Klinik. Thieme, Stuttgart New YorkGoogle Scholar
  4. 4.
    Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yü T-F (1977) Preliminary criteria for the classification of the acute arthritis of primary gout. Arthr Rheum 20:895–900CrossRefGoogle Scholar

Literatur

  1. 1.
    Dihlmann W (1987) Gelenke — Wirbelverbindungen, 3. Aufl. Thieme, Stuttgart New YorkGoogle Scholar
  2. 2.
    Keitel W (1993) Differentialdiagnostik der Gelenkerkrankungen, 4. Aufl. Fischer, JenaGoogle Scholar
  3. 3.
    Jaovesidha K, Rosenthal AK (2002) Calcium crystals in osteoarthritis. Curr Opin Rheumatol 14:298–302CrossRefGoogle Scholar
  4. 4.
    Schneider M (2001) Sonstige Kristallarthropathien. In: Zeidler H, Zacher J, Hiepe F (Hrsg) Interdisziplinäre klinische Rheumatologie. Springer, Berlin HeidelbergGoogle Scholar

Literatur

  1. 1.
    Genth E (1989) Infektionsbedingte Arthritiden. Internist 30:664–672PubMedGoogle Scholar
  2. 2.
    Hedström SA, Lidgren L (1994) Septic bone and joint lesions. In: Klippel JH, Dieppe PA (eds) Rheumatology. Mosby-Year Book Europe Limited, London, pp 3.1–3.10Google Scholar

Literatur

  1. 1.
    Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, Brown C, Cooke TD, Daniel W, Gray R, Greenwald R, Hochberg M, Howell D (1990) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hand. Arthr Rheum 33:1601–1610CrossRefGoogle Scholar
  2. 2.
    Buckland-Wright JC, Macfarlane DG, Clark B (1991) Osteophytes in the osteoarthritic hand: their incidence, size, distribution, and progression. Ann Rheum Dis 50:627–630PubMedGoogle Scholar

Literatur

  1. 1.
    Altman RD, Alarcon G, Appelrouth D, Bloch D, Borenstein D, Brandt K, Brown C, Cooke TD, Daniel W, Feldmann D, Greenwald R (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthr Rheum 34:505–514CrossRefGoogle Scholar

Literatur

  1. 1.
    Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M, Howell D (1986) Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthr Rheum 29:1039–1049CrossRefGoogle Scholar
  2. 2.
    Berrett JP (1990) Correlation of roentgenographic patterns and clinical manifestations of symptomatic idiopathic osteoarthritis of the knee. Clin Orthop 253:179–183Google Scholar

Literatur

  1. 1.
    Arzneimittelkommission der Deutschen Ärzteschaft (Hrsg) (2000) Kreuzschmerzen. Therapieempfehlungen der Arzneimittelkommission der deutschen Ärzteschaft, 2. Aufl.Google Scholar
  2. 2.
    Banzer D, Greitemann B, Güttler K, Hankemeier U, Hasenbring M et al (2005) Leitlinien-Clearingbericht „Chronischer Rückenschmerz“. Bd. 19 der Schriftenreihe des Ärztlichen Zentrums für Qualität in der Medizin (Hrsg)Google Scholar
  3. 3.
    Bigos S, Bowyer O, Braen G et al (1994) Acute low back problems in adults. Clinical practice guidelines No 14. AHCPR Publication No. 95-0642. Rockville MD: Agency for Health Care Policy and Research. Public Health Service, U.S. Department of Health and Human ServicesGoogle Scholar
  4. 4.
    Brune K, Hasenbring M, Krämer J, Niebling W, Raspe H et al (2001) Leitlinien-Clearing-Bericht „Akuter Rückenschmerz“. Bd. 7 der Schriftenreihe der Zentralstelle der Deutschen Ärzteschaft zur Qualitätssicherung in der Medizin (Hrsg) Zuckschwerdt, MünchenGoogle Scholar
  5. 5.
    Kohlmann T, Raspe H (1996) Der Funktionsfragebogen Hannover zur alltagsnahen Diagnostik der Funktionsbeeinträchtigung durch Rückenschmerzen (FFbH-R). Die Rehabilitation 35(1):I–VIIIPubMedGoogle Scholar
  6. 6.
    Mau W, Mahrenholtz M, Zeidler H (1994) Kreuzschmerzen-Diagnostik aus internistischer Sicht. Deutsches Ärzteblatt 91:C-441–C-452Google Scholar
  7. 7.
    Raspe H (2002) How epidemiology contributes to the management of spinal disorders. Best Pract Res Clin Rheumatol 16/1:9–21CrossRefGoogle Scholar

Literatur

  1. 1.
    Crofford LJ, Clauw DJ (2002) Fibromyalgia: where are we a decade after the American College of Rheumatology classification criteria were developed? Arthr Rheum 46:1136–1138CrossRefGoogle Scholar
  2. 2.
    Ecker-Egle MI, Egle UT (1993) Primäre Fibromyalgie. In: Egle UT, Hoffmann SO (Hrsg) Der Schmerzkranke. Schattauer, Stuttgart, S 530–543Google Scholar
  3. 3.
    Fitzcharles MA (2000) Is hypermobility a factor in fibromyalgia? J Rheumatol 27:1587–1589PubMedGoogle Scholar
  4. 4.
    Häntzschel H, Boche K (1999) Das Fibromyalgiesyndrom. Fortschritte der Medizin 117:26–31PubMedGoogle Scholar
  5. 5.
    Häntzschel H, Gruber G (1991) Weichteilrheumatismus unter besonderer Berücksichtigung der Generalisierten Tendomyopathie als funktionelles Syndrom. Z ärztl Fortbildung 85:417–420Google Scholar
  6. 6.
    Hermann JM, Geigges W, Schonecke OW (1996) Fibromyalgie. In: Uexküll T v. (Hrsg) Psychosomatische Medizin. Urban & Schwarzenberg, München, S 731–736Google Scholar
  7. 7.
    Keel P (1995) Fibromyalgie. Fischer, StuttgartGoogle Scholar
  8. 8.
    Keitel W (1999) Das Fibromyalgiesyndrom-außer Kontrolle? Fortschritte der Medizin 117:32–36PubMedGoogle Scholar
  9. 9.
    Kohl F (2001) Somatoforme Schmerzstörung und Fibromyalgie. Schmerz 14: 192–196CrossRefGoogle Scholar
  10. 10.
    Müller W, Lautenschläger I (1990) Die Generalisierte Tendomyopathie (GTM)-Teil 1: Klinik, Verlauf und Differenzialdiagnose. Z Rheumatol 49:11–21PubMedGoogle Scholar
  11. 11.
    Raspe HH, Häntzschel H, Boche K (1997) Fibromyalgiesyndrom. In: Deutsche Gesellschaft für Innere Medizin (Hrsg) Rationelle Diagnostik und Therapie in der Inneren Medizin. Urban & Schwarzenberg, MünchenGoogle Scholar
  12. 12.
    Wolfe F, Smythe H, Yunus MB, Bennet RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of a multicenter criteria committee. Arthr Rheum 33:160–172CrossRefGoogle Scholar

Literatur

  1. Binkley N, Bilezikian JP, Kendler DL, Leib ES, Lewiecki EM, Petak SM (2006) Official positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. J Clin Densitom 9:4–14PubMedCrossRefGoogle Scholar
  2. Boonen A, van der Linden SM (2006) The burden of ankylosing spondylitis. J Rheumatol (suppl) 78:4–11Google Scholar
  3. Consensus Development Conference (1993) Diagnosis, prophylaxis, and treatment of osteoporosis. Amer J Med 94:646–650CrossRefGoogle Scholar
  4. Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N (1994) Pel spective: the diagnosis of osteoporosis. J Bone Min Res 9:1137–1141CrossRefGoogle Scholar
  5. Painter SE, Kleerekoper M, Camacho PM (2006) Secondary osteoporosis: a review of the recent evidence. Endocr Pract 12:436–445PubMedGoogle Scholar
  6. Pfeilschifter J (2005) Postmenopausal and steroid-induced osteoporosis guideline-orientated prevention and treatment. Internist (Berl) 46(suppl 1):S31–7:S31–S37PubMedCrossRefGoogle Scholar
  7. Ringe JD (1994) Osteoporose: Wertigkeit der Densitometrie. Dtsch Ärzteb 91: B1862–1863Google Scholar
  8. Rosen CJ (2005) Clinical practice. Postmenopausal osteoporosis. N Engl J Med 353: 595–603PubMedCrossRefGoogle Scholar
  9. www.lutherhaus.de/osteo/leitlinien-dvo/index.phpGoogle Scholar

Copyright information

© Steinkopff Verlag 2007

Authors and Affiliations

  • H. Michels
    • 1
  • R. Häfner
    • 1
  • L. Köhler
    • 2
  • H. Zeidler
    • 3
  • P. Herzer
    • 4
  • G. R. Burmester
    • 5
  • E. Genth
    • 6
  • E. Gromnica-Ihle
    • 7
  • C. Specker
  • M. Schneider
    • 8
  • P. Vaith
    • 9
  • H. H. Peter
    • 9
  • W. L. Gross
    • 10
    • 11
  • B. Manger
    • 12
  • W. Keitel
    • 13
  • G. Weseloh
    • 14
  • B. Swoboda
    • 14
  • H. H. Raspe
    • 15
  • H. Häntzschel
    • 16
  • J. D. Ringe
    • 17
  • R. Dreher
  1. 1.RheumakinderklinikGarmisch-Partenkirchen
  2. 2.Rheumatologische FacharztpraxisHannover
  3. 3.Abteilung Rheumatologie der Medizinischen HochschuleHannover
  4. 4.München
  5. 5.Medizinischen Klinik Schwerpunkt Rheumatologie und Klinische ImmunologieUniversitätsklinikum ChariteBerlin
  6. 6.Rheumaklinik und Rheumaforschungsinstitut AachenAachen
  7. 7.RheumaklinikBerlin-BuchBerlin
  8. 8.Klinik für Endokrinologie Diabetologie und RheumatologieHeinrich-Heine-UniversitätDüsseldorf
  9. 9.Abteilung Rheumatologie und Klinische Immunologie der Medizinischen UniversitätsklinikAlbert-Ludwigs-UniversitätFreiburg
  10. 10.Medizinischen KrankenhausabteilungRheumaklinikBad Bramstedt
  11. 11.Poliklinik für RheumatologieMedizinische Universität zu LübeckLübeck
  12. 12.Medizinischen Klinik III mit PoliklinikUniversität Erlangen-NürnbergErlangen
  13. 13.Vogelsang
  14. 14.Abteilung für Orthopädische Rheumatologie Orthopädische UniversitätsklinikWaldkrankenhaus St. MarienErlangen
  15. 15.Institutes für Sozialmedizin der MedizinischenUniversität zu LübeckLübeck
  16. 16.Medizinisch-Poliklinischen Institutes der UniversitätLeipzig
  17. 17.Medizinischen Klinik IVKlinikum LeverkusenLeverkusen

Personalised recommendations